Effector Therapeutics Funding: $325M Raised, Series A (2013)

Effector Therapeutics funding overview

Effector Therapeutics is based in San Diego, California. Effector Therapeutics has raised $325M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in January 2013. The round record for Effector Therapeutics runs through 2013; nothing later has been disclosed. Investors on record include GlaxoSmithKline's SR One, Novartis Venture Funds, Astellas Venture Management, Abingworth, Osage University Partners, U.S. Venture Partners and 3 others. 9 distinct backers are named across the disclosed rounds.

Effector Therapeutics at a glance

Total raised: $325M
Latest round: Series A
Latest round date: January 2013
Headquarters: San Diego, California
Notable investors: GlaxoSmithKline's SR One, Novartis Venture Funds, Astellas Venture Management, Abingworth, Osage University Partners, U.S. Venture Partners, Mission Bay Capital, Pfizer Venture Investments

Frequently asked about Effector Therapeutics funding

How much has Effector Therapeutics raised?: Effector Therapeutics has raised $325M in total disclosed funding across the rounds on record.
Who has invested in Effector Therapeutics?: GlaxoSmithKline's SR One, Novartis Venture Funds, Astellas Venture Management, Abingworth, Osage University Partners, U.S. Venture Partners are named among the investors backing Effector Therapeutics.
What was the latest Effector Therapeutics funding round?: The most recent disclosed round is a Series A, announced in January 2013.
Where is Effector Therapeutics based?: Effector Therapeutics is based in San Diego, California.
When did Effector Therapeutics last raise?: The last disclosed Effector Therapeutics round closed in January 2013 at Series A.

Effector Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

Effector Therapeutics Funding: $325M Raised, Series A (2013)

Effector Therapeutics funding overview

Effector Therapeutics at a glance

Frequently asked about Effector Therapeutics funding

Companies related to Effector Therapeutics (18)

Browse related funding lists (9)